Joel T.May

Partner

Atlanta + 1.404.581.8967

Connect:

Share

Joel May is a corporate lawyer with more than 20 years of experience. He has recently represented clients in more than $20 billion of domestic and international corporate financing transactions in the manufacturing, consumer products, chemical products, real estate, e-commerce, telecommunications, and information management industries. These matters have included public equity and debt offerings, initial public offerings (IPOs), special purpose acquisition companies (SPACs) and related private investment in public equity (PIPE) transactions, Rule 144A high yield offerings, private capital raisings, reorganizations, restructurings, recapitalizations, and other M&A transactions as well as counseling public companies and their boards of directors on a broad range of corporate governance and compliance matters.

Joel joined the Atlanta Office in 2012 after spending the first part of his career in Jones Day's Chicago Office. He currently serves as the administrative partner for Atlanta. Joel's notable clients include Asbury Automotive Group, Bespoke Capital Acquisition Corp, Bunge Ltd., FleetCor Technologies, Flowers Foods, Hanesbrands, HD Supply, Helios Technologies, Mark Capital, Milliken, Newell Brands, PGT Innovations, PureCycle Technologies, Nutrien, Rayonier, Roper Technologies, Sonoco, Southern Company, Vintage Wine Estates, and VSE Corporation.

Joel has been recognized as a leading lawyer by The Legal 500 United States. He is a member of the American Bar Association and the State Bar of Georgia.

Joel is a member of the board of directors for Make-A-Wish Georgia and serves on the Metro Atlanta Chamber of Commerce.

Experience

  • APRINOIA Therapeutics and Ross Acquisition Corp II announce business combinationJones Day is advising Ross Acquisition Corp II in the business combination with APRINOIA Therapeutics Inc. pursuant to which APRINOIA and Ross will each become a wholly owned subsidiary of the combined company, APRINOIA Therapeutics Holdings Limited, a newly formed entity.
  • Flowers Foods acquires Papa Pita BakeryJones Day is advising Flowers Foods, Inc. in its acquisition of Papa Pita Bakery, a leading manufacturer and distributor of high-quality bagels, tortillas, breads, buns, English muffins, and flat breads.
  • Roper Technologies sells majority stake in industrial businesses to Clayton Dubilier & Rice, LLC for $2.6 billionJones Day advised Roper Technologies, Inc. on the sale of a majority stake in its industrial businesses, including its entire Process Technologies segment and the industrial businesses within its Measurement & Analytical Solutions segment, to an affiliate of Clayton Dubilier & Rice, LLC, for $2.6 billion in cash and contingent consideration of up to $51 million.
  • Nutrien completes US$1 billion Senior Unsecured Notes offeringJones Day represented Nutrien Ltd. in connection with a public offering of US$1 billion of Senior Notes, consisting of (i) US$500 million aggregate principal amount of 5.900% Senior Notes due 2024 and (ii) US$500 million aggregate principal amount of 5.950% Senior Notes due 2025.
  • Rayonier establishes $300 million at-the-market equity programJones Day represented Rayonier Inc. in connection with establishing an at-the-market equity program for the offering and sale of up to $300 million of its Common Shares.
  • Nutrien establishes $4.5 billion commercial paper facilityJones Day represented Nutrien Ltd., an integrated provider of crop inputs and services, in connection with the establishment of a $4.5 billion commercial paper facility.
  • NioCorp to combine with GX Acquisition Corp. IIJones Day is advising NioCorp Developments Ltd. (TSX: NB; OTCQX: NIOBF) in its business combination with GX Acquisition Corp. II (Nasdaq: GXII), a publicly-traded special purpose acquisition corporation.
  • Newell Brands completes $1 billion Senior Notes offeringJones Day represented Newell Brands Inc. in connection with a public offering of $1 billion of Notes, consisting of $500 million aggregate principal amount of 6.375% Senior Notes due 2027 and $500 million aggregate principal amount of 6.675% Senior Notes due 2029.
  • Labcorp to spin off Clinical Development businessJones Day is advising Labcorp (NYSE: LH), a leading global life sciences company, in its consideration of whether to pursue a spin-off of its Clinical Development business to its shareholders through a tax-free transaction.
  • Aaron's Company acquires BrandsMart U.S.A. for $230 millionJones Day advised The Aaron's Company, Inc., a leading technology-enabled, omnichannel provider of lease-to-own and purchase solutions, on its acquisition of BrandsMart U.S.A. for $230 million.
  • PureCycle Technologies completes $250 million private placement of Common Stock and WarrantsJones Day represented PureCycle Technologies, Inc. in connection with its private placement of $250 million of Common Stock and Warrants.
  • Roper Technologies sells TransCore to Singapore Technologies Engineering for $2.68 billionJones Day advised Roper Technologies, Inc. in the sale of TransCore Partners, LLC and TLP Holdings, LLC to an affiliate of Singapore Technologies Engineering Ltd. for $2.68 billion in cash, subject to customary purchase price adjustments.
  • Asbury Automotive Group acquires Larry H. Miller Dealerships and Total Care Auto for $3.2 billionJones Day advised Asbury Automotive Group, Inc. (NYSE: ABG), one of the largest automotive retail and service companies in the U.S., in its acquisition of Larry H. Miller Dealerships, and Total Care Auto, Powered by Landcar for $3.2 billion.
  • Nutrien completes $300 million tender offer and redemption of $1.8 billion of debt securitiesJones Day represented Nutrien Ltd., the world's largest provider of crop inputs and services, in connection with the tender offer by Nutrien Ltd. and its wholly-owned subsidiaries, Agrium Inc. and Potash Corporation of Saskatchewan Inc., to purchase for cash up to $300 million in aggregate purchase price of their respective debt securities.
  • Koch invests in Footprint at $1.6 billion valuationJones Day advised Koch Strategic Platforms in its $150 million investment in the Class C Preferred Stock of Footprint International Holdco, Inc.
  • Luminex participates in business combination with Global Consumer Acquisition Corp.Jones Day advised Centre Lane Partners, LLC portfolio company Luminex Home Decor & Fragrance Holding Corporation in the attempted business combination with GP Global Limited and Global Consumer Acquisition Corp. (GACQ), a publicly-traded special purpose acquisition company.
  • Asbury Automotive completes $600.6 million Shares of Common Stock and $1.4 billion Senior Notes offeringJones Day represented Asbury Automotive Group, Inc. (the "Company") in connection with (i) its underwritten public offering (the "Common Stock Offering") of 3,795,000 Shares of its Common Stock, par value $0.01 per share (the "Shares") resulting in gross proceeds of approximately $600.6 million and (ii) its offering of Senior Notes (the “Notes Offering”), consisting of $800 million aggregate principal amount of 4.625% Senior Notes due 2029 (the “2029 Notes”) and $600 million aggregate principal amount of 5.000% Senior Notes due 2032 (the “2032 Notes” and, together with the 2029 Notes, the “Notes”).
  • Milliken & Company acquires Encapsys, LLCJones Day advised Milliken & Company in its acquisition of Encapsys, LLC, a world leader in microencapsulation delivery systems for the building, construction, paper, bedding and personal care industries.
  • Milliken & Company completes Senior Notes offeringJones Day represented Milliken & Company, an industrial manufacturer that is active in a breadth of disciplines, including specialty chemical, floor covering, performance, and protective textile materials, in connection with its private placement of Senior Notes and revolving credit facility.
  • Leading financial services company arranges $1.6 billion delayed draw term loan facilityJones Day represented a leading financial services company, as left lead arranger and administrative agent, in connection with a $1.6 billion delayed draw term loan facility provided by a syndicate of lenders to a major producer of construction aggregates and aggregates-based construction materials to finance the strategic acquisition of a leading supplier of aggregates and ready-mixed concrete.
    • View All

    January 17 - December 12, 2023 Firm Hosted

    Public Company Speaker Series

    December 2022 Commentary

    SEC Adopts Final Rules Regarding Rule 10b5-1 Trading Plans and Related Disclosures

    December 2022 Commentary

    SEC Updates Guidance on Non-GAAP Financial Measures

    November 2022 Alert

    The European Parliament Adopts New Sustainability Reporting Rules

    November 2022 Alert

    SEC Adopts Final Dodd-Frank Act Clawback Rules

    November 2022 White Paper

    SEC Adopts Final Dodd-Frank Act Clawback Rules: An A-to-Z Explanation

    October 18, 2022 Firm Hosted

    Hot Topics in Executive Compensation and Related SEC (and Other) Developments: October Updates

    September 15, 2022 Firm Hosted

    Jones Day's 2022 Pittsburgh Speaker Series: Beyond the 2022 Proxy Season: Activism, Disclosure, and Governance Considerations and Trends for 2023

    September 2022 White Paper

    SEC Adopts Pay Versus Performance Disclosure Rules

    August 2022 Commentary

    Delaware Authorizes 102(b)(7) Exculpation of Senior Officers
    View All

    Speaking Engagements

    • December 1, 2016
      Jones Day/EY - Emerging Risks in Financial Reporting and Disclosures
    • October 27, 2016
      Georgia Bas Association / 35th Annual Business Law Institute - What Keeps In-House Law Departments Up At Night
    • January 7, 2016
      Jones Day Atlanta Hosts Diversity Meet & Greet
    • November 9, 2015
      Atlanta Bar Association / Scrutinizing Executive Compensation - The SEC's New Clawback and Pay Ratio Rules
    • March 23, 2012
      Introduction to the Resale of Restricted and Control Securities, ICLE Basic Securities Law Program

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.